Search

everythinglearnresearchcommunity

for

Search:↓

Some patients developed hair loss after islet cell transplant possibly due to their immune-suppressing medications.

Certain medications can impact metabolic syndrome, with some improving conditions like high blood sugar and others having no effect.

Topical corticosteroids are the main treatment for Erosive Pustular Dermatosis, but recurrence is common after stopping treatment.

A woman developed permanent hair loss after a face-lift surgery despite various treatments.

Phenobarbital-loaded chitosan nanoparticles are promising for preventing hair loss from chemotherapy.

Omalizumab may cause temporary hair loss, especially in women aged 18-60.

Early diagnosis and treatment of nail lichen planus in children can prevent permanent nail damage.

The document explains how the immune system reacts to organ transplants and the treatments used to prevent rejection.

The document explains hair and nail biology, common hair loss conditions and treatments, oral and genital skin diseases, and the risks and treatments associated with squamous cell carcinoma.

Certain drugs can cause lupus, stopping these drugs is the main treatment. NB-UVB phototherapy clears psoriasis faster when applied three times a week. Monoclonal antibodies and oral pimecrolimus are effective in treating psoriasis. Smoking and drinking are linked to psoriasis in men. No direct link between low iron and hair loss was found. Vaccines are effective against genital herpes and human papillomavirus type 16.

Apremilast shows promise for several skin conditions but needs more research.

Platelet-rich concentrates can be an alternative treatment for oral lichen planus, especially when steroids don't work.

Abrocitinib effectively treated severe atopic dermatitis and mild alopecia areata in a 12-year-old boy after dupilumab failed.

A woman's vitiligo improved with tofacitinib treatment, and her skin color remained even after stopping the medication, but there are concerns about cancer risk.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Tofacitinib helped some young children with severe hair loss grow their hair back without bad side effects.

Dapsone improved pustular psoriasis in patients who didn't respond to other treatments and is considered a well-tolerated option.

The combination of cyclosporine and PUVA might help treat severe alopecia areata.

Antiviral medication valganciclovir may improve skin and hair in Trichodysplasia Spinulosa patients.

Mycophenolate mofetil helped reduce steroid use in treating a dog's autoimmune skin disease.

Individualized treatment and psychological support improved the patient's quality of life and appearance despite medication side effects.

Tofacitinib may be safe and effective for treating certain skin conditions in children.

The document covers various dermatological treatments and conditions.

Azathioprine may help with severe hair loss, a new topical treatment could counteract hair thinning, and trichoscopy can diagnose hair-pulling disorder effectively.

Prednisone has risks for lupus patients, isotretinoin is safe for mental health, transplant patients risk skin cancer, and various treatments are effective for specific skin conditions.

The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.

Graft-versus-host disease is a complication where donor immune cells attack the recipient's body, often affecting the skin, liver, and gastrointestinal tract.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

New psoriasis treatments are effective but come with side effects and risks.

Certain drugs are effective for skin conditions like psoriasis, vitiligo, and hair loss.